MAIA Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	73	17	38	-	-
Market Cap Growth	15.66%	-56.72%	-	-	-
Enterprise Value	65	9	27	-11	-0
PE Ratio	-	-0.84	-2.37	-	-
PB Ratio	-7.63	34.83	4.52	-	-
P/FCF Ratio	-3.31	-1.27	-3.18	-	-
P/OCF Ratio	-3.31	-1.27	-3.18	-	-
EV/EBITDA Ratio	-1.51	-0.48	-1.69	0.91	0.03
EV/EBIT Ratio	-1.51	-0.48	-1.69	0.91	0.03
EV/FCF Ratio	-2.69	-0.73	-2.27	2.56	0.09
Debt / Equity Ratio	-	-	-	-	-0.15
Debt / EBITDA Ratio	-	-	-	-	-0.07
Debt / FCF Ratio	-	-	-	-	-0.27
Quick Ratio	1.69	1.45	3.35	4.93	0.39
Current Ratio	1.77	1.53	3.61	4.97	0.44
Interest Coverage	-13823.87	-2880.09	-2327.10	-14.11	-204.94
Return on Equity (ROE)	-2189.20%	-520.90%	-178.80%	-427.80%	-
Return on Assets (ROA)	-282.80%	-233.20%	-135.10%	-207.10%	-
Return on Capital (ROIC)	346.01%	-4226.58%	-190.13%	-84.81%	244.99%
Earnings Yield	-32.43%	-118.90%	-42.22%	-	-
FCF Yield	-18.18%	-78.60%	-31.48%	-	-
Buyback Yield / Dilution	-60.35%	-42.95%	-75.75%	-19.23%	-
Total Shareholder Return	-60.35%	-42.95%	-75.75%	-19.23%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).